The vascular biology of calcification

Seminars in Dialysis

Volumn 20, Issue 2, 2007, Pages 103-109

  Shroff, Rukshana C ^a   Shanahan, Catherine M ^b,c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BONE MINERALIZATION; CALCINOSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CYTOLOGY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; OSTEOPOROSIS; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CALCINOSIS; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; HUMANS; KIDNEY FAILURE, CHRONIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOPOROSIS;

EID: 33947303700     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00255.x     Document Type: Article

References (57)

1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208-2218, 2004
2. Goodman WG, London G, Amann K, Block GA, Giachclli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N: Vascular calcification in chronic kidney disease. Am J Kidney Dis 43:572-579, 2004
3. Virchow R: Cellular pathology. As based upon physiological and pathological histology. Lecture XVI - Atheromatous affection of arteries. 1858. Nutr Rev 47:23-25, 1989
4. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168-2176, 1999
5. Tyson KL, Reynolds JL, McNair R, Zhang Q. Weissberg PL, Shanahan CM: Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23:489-494, 2003
6. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL: Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87:1055-1062, 2000
7. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857-2867, 2004
8. London GM, Marchais SJ, Guerin AP, Metivier F: Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 14:525-531, 2005
9. Proudfoot D, Shanahan CM: Biology of calcification in vascular cells: intima versus media. Herz 26:245-251, 2001
10. Moe SM, Chen NX: Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95:560-567, 2004
11. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-647, 2002
12. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, Demer LL: Multilineage potential of cells from the artery wall. Circulation 108:2505-2510, 2003
13. Bostrom K, Tsao D, Shen S, Wang Y, Demer LL: Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276:14044-14052, 2001
14. Shanahan CM, Proudfoot D, Farzaneh-Far A, Weissberg PL: The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Expr 8:357-375, 1998
15. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM: Osteopontin is synthesized by macrophage, smooth muscle, and endolhelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14:1648-1656, 1994
16. Zebboudj AF, Imura M, Bostrom K: Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 277:4388-4394, 2002
17. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81, 1997
18. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E: Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 21:142-144, 1999
19. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone MA Jr, Falb D, Huszar D: A role for smad6 in development and homeoslasis of the cardiovascular system. Nat Genet 24:171-174, 2000
20. Davies MR, Lund RJ. Mathew S, Hruska KA: Low turnover ostcodyslrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 16:917-928, 2005
21. Davies MR. Lund RJ, Hruska KA: BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 14:1559-1567, 2003
22. Ramirez F, Pereira L: Mutations of extracellular matrix components in vascular disease. Ann Thorac Surg 67:1857-1858, 1999
23. Fietta P, Manganelli P: Is fibrillin-1 the link between ankylosing spondylitis and Marfan's syndrome? J Rheumatol 29:1808, 2002
24. Spicer SS, Lewis SE, Tashian RE, Schulte BA: Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification. Am J Pathol 134:947-954, 1989
25. Cotter M, Connell T, Colhoun E, Smith OP, McMahon C: Carbonic anhydrase II deficiency: a rare autosomal recessive disorder of ostcopetrosis, renal tubular acidosis, and cerebral calcification. J Pediatr Hematol Oncol 27:115-117, 2005
26. Johnson K, Polewski M, van Etten D, Terkeltaub R: Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arterioscler Thromb Vasc Biol 25:686-691, 2005
27. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Hohne W, Schauer G, Lehmann M, Roscioli T, Schnabel D, Epplen JT, Knisely A, Superti-Furga A, McGill J, Filippone M, Sinaiko AR, Vallance H, Hinrichs B, Smith W, Ferre M, Terkeltaub R, Nurnberg P: Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 34:379-381, 2003
28. Schäfer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuín-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357-366, 2003
29. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G: Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64:1118-1129, 1979
30. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM: Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16:2920-2930, 2005
31. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficienl mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268, 1998
32. Collin-Osdoby P: Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 95:1046-1057, 2004
33. Ikushima M, Rakugi H, Ishikawa K, Maekawa Y, Yamamoto K, Ohta J, Chihara Y, Kida I, Ogihara T: Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem Biophys Res Commun 339:827-832, 2006
34. Nabeshima Y: Ectopic calcification in Klotho mice, Clin Calcium 12:1114-1117, 2002
35. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX: Uremia induces the osteoblast differentiation factor Cbfal in human blood vessels. Kidney Int 63:1003-1011, 2003
36. Proudfoot D, Davies JD, Skepper JN, Weissberg PL, Shanahan CM: Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 106:3044-3050, 2002
37. Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL: High-density lipoprotein regulates calcification of vascular cells. Circ Res 91:570-576, 2002
38. Demer LL: Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol 31:737-741, 2002
39. Hunter GK, Kyle CL, Goldberg HA: Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontinmediated inhibition of hydroxyapatite formation. Biochem J 300 (Pt 3):723-728, 1994
40. Giachelli CM, Lombard) D, Johnson RJ, Murry CE, Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358, 1998
41. Li X, Yang HY, Giachelli CM: Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98:905-912, 2006
42. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-E17, 2000
43. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H: Vascular calcification and inorganic phosphate. Am J Kidney Dis 38:834-S37, 2001
44. Ketteler M, Vermeer C, Wanner C, Westenfeld R, Jahnen-Dechent W, Floege J: Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin. Blood Purif 20:473-476, 2002
45. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC: Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 15:1392-1401, 2004
46. Bro S, Borup R, Andersen CB, Moeller F, Olgaard K, Nielsen LB: Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficienl mice. Arterioscler Thromb Vasc. Biol 26:570-575, 2006
47. Kaden JJ, Bickelhaupt S, Grobholz R, Vahl CF, Hagl S, Brueckmann M, Haase KK., Dempfle CE, Borggrefe M: Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis 13:560-566, 2004
48. Price PA, Faus SA, Williamson MK: Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vase. Biol 18:1400-1407, 1998
49. Wilmer WA, Magro CM: Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 15:172-186, 2002
50. Brancaccio D, Biondi ML, Gallieni M, Turri O, Galassi A, Cecchini F, Russo D, Andreucci V. Cozzolino M: Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol 25:548-552, 2005
51. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827-833.2003
52. Osawa M, Tian W, Horiuchi H, Kaneko M, Umetsu K: Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels. Hum Genet 116:146-151, 2005
53. Lomashvili KA, Khawandi W, O'Ncill WC: Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16:2495-2500, 2005
54. Watson KE, Abrolat ML, Malone LL: Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755-1760, 1997
55. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943-1951, 2004
56. Nitla K, Akiba T, Uchida K, Otsubo S. Takei T, Yumura W, Kabaya T, Nihei H: Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1886-1889, 2004
57. McClung MR: Inhibition of RANKL as a treatment for osteoporosis: preclinical and early clinical studies. Curr Osteoporos Rep 4:28-33, 2006